Dossier
Splenda
Coverage of Splenda in the Nexus archive.
- Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
Tate & Lyle has agreed to a £2.7bn takeover by US rival Ingredion, which could result in nearly 500 jobs being at risk globally. The deal represents a significant loss for London's struggling stock market.
- Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
Tate & Lyle, a UK-based company producing artificial sweeteners like Splenda, has agreed to a £2.7bn takeover by US rival Ingredion. The deal, valued at 615p per share (60% above pre-takeover prices), could jeopardize nearly 500 global jobs and marks another setback for London's struggling stock market.